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Dr Tirone E. David (Toronto, Ontario, Canada). I would like
to congratulate Dr Faber and his colleagues from the Cleveland
Clinic for having attempted to demonstrate the relative values of
mitral valve repair and mitral valve replacement in patients with
mitral regurgitation caused by myxomatous degeneration and as-
sociated coronary artery disease. I have to confess that I do not
understand the statistical methods he used to adjust for the differ-
ences in the patients’ clinical profile, but I trust Eugene Blackstone
so much that I have to accept their conclusions.
What is evident to me, however, is that your patients who had
mitral valve replacement were operated on much earlier in your
experience than those who had mitral valve repair. Actually, 62%
of your patients who had mitral valve replacement were operated
on before 1990, and 73 of those who had mitral valve repair were
operated on after 1990. This alone suggests to me a change in
approach at your institution, that the surgeons who are facing the
problem decided to change the way they manage their problem. In
addition, patients who had mitral valve replacement were much
older, they are much more symptomatic, and they had worse
ventricular function than patients who had mitral valve repair.
There was no mention in your presentation or your manuscript
that I reviewed, thanks to you, as to whether the papillary muscles
and chordae tendineae were preserved during mitral valve replace-
ment. Years ago we published an article showing that mitral valve
repair or replacement with the preservation of the chordae tendi-
neae had similar 10-year survival if the patients had isolated mitral
valve regurgitation caused by myxomatous disease.
I have a couple of questions for you, Dr Faber. Were the
papillary muscles preserved in any of your patients, and if they
were, was the result the same?
The second question is related to the ITA. We have shown over
and over that revascularization of the internal descending artery
with the left ITA enhances life span. Forty-five percent of your
mitral valve repairs used the ITA, whereas this was the case in only
15% of the replacements. Could this difference alone account for
most of the difference found in survival?
Finally, there must be a number of patients in whom, even after
1990, when your surgeons were more experienced in mitral valve
repair, your surgeons attempted to repair the mitral valve, and then,
after a while, 30 minutes or an hour, they abandoned the procedure
and replaced the valve. Those patients, if they were lumped to-
gether with the elective mitral valve replacements, had a much
worse prognosis than those who had mitral valve replacement to
start with.
Dr Faber. Dr David, thank you very much for your kind
comments, and those are very important issues that you pointed
out. I would like to say that we did not have the information about
the preservation of the subvalvular apparatus on the operative
reports of the patients, so we could not say which ones we
preserved and which ones we did not preserve. I know about the
results of your article, and I agree with them, but we could not
analyze that data, and that probably could be accounting for some
of the differences that we saw.
Dr David. I am sorry to dwell on this issue. Did you take a look
at temporal response of mitral valve replacement as well? In other
words, of the patients who were operated on after 1990 and had
mitral valve replacement, did those patients do better than those
operated on in 1973?
Dr Faber. I do not know the answer for this. We did not look
into that. The only thing we know is that after we gained more
experience with repair, we started doing more and more of those,
but we did not look specifically at the time frame of those.
Therefore I could not answer this question for you.
About the ITA differences in survival, yes, I agree with that,
and it has been shown that there is a difference in survival. Still,
this, in the beginning of our experience, was based on the decision
of the surgeon. Therefore I could not say why they used that. But
I agree with your comments, and lately, that is what we use for the
revascularization of the LAD.
What was your last question?
Variable Value Value chosen
Age See above
BUN See above
Bilirubin See above
NYHA class
II 3.7
III 9.6
IV 18.3
LV dysfunction* 11.9
Atrial fibrillation 8.5
Chordal rupture† 1.2
Ever smoked 11.7
Diabetes§ 9.7
Ventricular arrhythmias 1.7
Total
BUN, Blood urea nitrogen; LV, left ventricular.
*Grade 3 (moderately severe) or 4 (severe) left ventricular dysfunction.
†Only those of the posterior leaflet.
§Pharmacologically treated (real hypoglycemic agents or insulin).
Third, sum all the numbers in the column marked “Value chosen.”
Fourth, interpret the total. The total is the estimated 10-year survival
difference in percentage. If the sum is positive, repair is favored; if
negative, replacement is recommended. Approximate error of the survival
difference is 5.5%.
Example: The patient is 70 years old (8.9) in sinus rhythm (0 for atrial
fibrillation) without ventricular ectopy (0) but with only posterior
chordal rupture and leaflet prolapse (1.2) in NYHA class III (9.6)
with 3-system coronary artery disease and well-preserved left ventric-
ular function (0) who has never smoked (0), has no history of diabetes
(0), has a blood urea nitrogen value of 18 (13.0), and has a bilirubin
value of 0.8 (1.14). The total score is 9.96  5.5, meaning mitral valve
repair is recommended.
Appendix 2. Continued
Age Value BUN Value Bilirubin Value
65 7.7 22 10.7 0.9 1.28
70 8.9 24 9.6 1.0 1.42
75 10.2 26 8.5 1.1 1.56
80 11.6 28 7.5 1.2 1.71
85 13.1 30 6.5 1.4 1.99
35 4.1 1.8 2.55
40 1.9 2.2 3.12
BUN, Blood urea nitrogen.
Gillinov et al Surgery for Acquired Cardiovascular Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 6 1361
A
CD
Dr David. The issue of attempting mitral valve repair. Because
it is a long procedure because the patient also needs myocardial
revascularization, after whatever each one of us allows ourselves
for repair—30 minutes, 60 minutes—some of us then abandon the
procedure and perform mitral valve replacement instead. Those
patients are at a disadvantage because of the long operative pro-
cedure.
Dr Faber. Sure. Those patients we analyzed with intention to
treat, which means that if they were in for repair and they had their
valves replaced at the end, they would count as the repair patients
in the repair group. That is the way we looked into that data.
Dr David H. Adams (New York, NY). I just had one comment
about your data and that was that it looked like age was one of the
predictors of valve replacement and anterior leaflet prolapse was
one of the predictors of valve replacement, and, at least in your
conclusion, it looks like if you have poor ventricular function, you
might be more likely to go straight to valve replacement. Therefore
given those 3 variables, I am sure all of us are interested to
understand today in the Cleveland Clinic, particularly because Dr
David pointed out that a lot of your patients are in the current era
of valve repair, what percentage of patients with anterior leaflet
prolapse actually undergo repair?
Second, is there an age cutoff for repair? At 80 years or 85
years do you go in and basically replace the valve?
Third, in patients who have depressed left ventricular function,
are you today more likely to go straight to valve replacement?
Dr Faber. I have numbers here, but I am going to start with the
last one. No, we tried to repair these valves. And especially in
patients who have good left ventricular function, we are going to
at least attempt to repair those valves. There is no age cutoff to
choose between repair and replacement, and we tried to show that
in our experience if a patient has good left ventricular function and
is 70 years of age, for example, the mitral valve repair is going to
be attempted, and we always try to do that.
Concerning how many patients had anterior mitral prolapse,
20% of the total patients had anterior leaflet only prolapse: with
mitral valve replacement, it was 21%; with mitral valve repair, it
was 19%. Twenty-three percent of the whole group had bileaflet
prolapse, and of course, as I showed, those are the patients who are
more prone to have their valves replaced in the beginning of our
experience.
Dr Adams. And what about poor ventricular function? If a
patient today comes to the operating room with an ejection fraction
of 20%, are you trying to do repair or replacement or what?
Dr Faber. I particularly think that we still need to try to repair
those valves if it is a simple repair, but we showed in our data that
those are the patients who are not going to benefit from the repair.
Therefore it is fair to say that if you replace those valves, you are
going to be back there.
Dr O. Wayne Isom (New York, NY). I have a question, because
if you look at some of the Cleveland Clinic brochures that we all
get, by my calculations, this would be 26 years and 700 patients.
That is about 27 patients a year. That is about one patient who
needs a mitral valve repair or replacement and a coronary bypass
every other week. What about the numbers in there, the later years
or the earlier years? You have got to be doing more than one every
other week.
Dr Faber. We extracted those 700 patients from a total of 1500
patients. That was the total number of patients we had in this
period with just pure degenerative mitral valve disease. We came
up with about 700 patients.
Dr Isom. How did you decide it was degenerative?
Dr Faber. We looked at echocardiography, we looked at
pathology, and we looked at the operative note and the surgeon’s
description of the valve. Those were the 3 ways that we looked at
that. And we tried to exclude them and come up with the cleanest
data. Therefore we checked on the patients who had ischemic
mitral regurgitation in our Cardiovascular Information Registry,
and we excluded those patients and also patients with endocarditis
and any other pathologies.
Dr Isom. Let me just ask a question. I have admired Dr
Blackstone for years, but many times after I read the article I cannot
tell whether he is for it or against it. Today, if a patient comes into the
Cleveland Clinic with a 30% ejection fraction, fairly extensive triple-
vessel disease, and needs 4 or 5 bypasses and has a ruptured chordae
posteriorly but anterior leaflet prolapse is quite a bit, and therefore you
are going to have to do something to that, what are you going to start
out doing on the mitral valve? Are you going to repair it, or are you
going to replace it or do it after you do the coronary bypasses before?
How do you approach that?
Dr Faber. I think that is a very fair question. The way we look
into that, it is based on our data. You would be okay if you just
replace those valves because those are the subset of patients who
did not do that well with the repair. But it depends on the expe-
rience of the surgeon. If you have more experienced surgeons, they
are going to try to do a quick repair if they can, but if you just
replace those valves, that would be a fair attitude.
Dr Endre Bodnar (Northwood, United Kingdom). I have a
comment. I missed a lot of the ejection fractions of the 2 groups.
Nowadays that is the first data one would look at before deciding
for repair or replacement, and it is a great pity that in such a huge
patient material this important information was missing. My ques-
tion is that the frequency of repair over the years from the late
1970s to mid-1990s quadrupled. Now, why was that, because your
patient material has changed so repair was a more likely procedure
or because the surgeon’s attitude has changed, in which case, are
you justified to lump all these patients into one basket?
Dr Faber. Thank you for your question. I think that all surgical
procedures and all surgeons go through a learning curve. As you
do more and you get better results, you keep doing more, and those
would account for this increase in our repair throughout the years,
and that I think would be the biggest effect on this. I think once
you pass through the learning curve, you are going to be more
comfortable and you are going to be able to do better repairs on
most degenerated valves than when you start your experience with
that.
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